{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:29:10Z","timestamp":1793035750196,"version":"4.5.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T00:00:00Z","timestamp":1633392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T00:00:00Z","timestamp":1633392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004156","name":"Mahidol University","doi-asserted-by":"publisher","award":["A32\/2561"],"award-info":[{"award-number":["A32\/2561"]}],"id":[{"id":"10.13039\/501100004156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004396","name":"Thailand Research Fund","doi-asserted-by":"publisher","award":["RSA6280075"],"award-info":[{"award-number":["RSA6280075"]}],"id":[{"id":"10.13039\/501100004396","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s11030-021-10292-6","type":"journal-article","created":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T00:20:11Z","timestamp":1633479611000},"page":"467-487","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["ABCpred: a webserver for the discovery of acetyl- and butyryl-cholinesterase inhibitors"],"prefix":"10.1007","volume":"26","author":[{"given":"Aijaz Ahmad","family":"Malik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suvash Chandra","family":"Ojha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nalini","family":"Schaduangrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1040-663X","authenticated-orcid":false,"given":"Chanin","family":"Nantasenamat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,5]]},"reference":[{"issue":"1","key":"10292_CR1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/ene.13439","volume":"25","author":"CA Lane","year":"2018","unstructured":"Lane CA, Hardy J, Schott JM (2018) Alzheimer\u2019s disease. Eur J Neurol 25(1):59\u201370","journal-title":"Eur J Neurol"},{"issue":"R1","key":"10292_CR2","doi-asserted-by":"publisher","first-page":"R4","DOI":"10.1093\/hmg\/ddq142","volume":"19","author":"K Bettens","year":"2010","unstructured":"Bettens K, Sleegers K, Van Broeckhoven C (2010) Current status on Alzheimer disease molecular genetics: from past, to present, to future. Hum Mol Genet 19(R1):R4\u2013R11","journal-title":"Hum Mol Genet"},{"key":"10292_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.eswa.2020.113213","volume":"150","author":"MLB Pulido","year":"2020","unstructured":"Pulido MLB, Hern\u00e1ndez JBA, Ballester M\u00c1F, Gonz\u00e1lez CMT, Mekyska J, Sm\u00e9kal Z (2020) Alzheimer\u2019s disease and automatic speech analysis: a review. Expert Syst Appl 150:113213","journal-title":"Expert Syst Appl"},{"issue":"3","key":"10292_CR4","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/alz.12068","volume":"16","author":"Alzheimer's Association","year":"2020","unstructured":"Alzheimer\u2019s Association (2020) Alzheimer\u2019s disease facts and figures. Alzheimers Dement 16(3):391\u2013460","journal-title":"Alzheimers Dement"},{"key":"10292_CR5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40035-018-0107-y","volume":"7","author":"X Du","year":"2018","unstructured":"Du X, Wang X, Geng M (2018) Alzheimer\u2019s disease hypothesis and related therapies. Transl Neurodegener 7:2","journal-title":"Transl Neurodegener"},{"issue":"1","key":"10292_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2174\/1389557023406494","volume":"2","author":"X Barril","year":"2002","unstructured":"Barril X, Kalko SG, Orozco M, Luque FJ (2002) Rational design of reversible acetylcholinesterase inhibitors. Mini Rev Med Chem 2(1):27\u201336","journal-title":"Mini Rev Med Chem"},{"issue":"3\u20134","key":"10292_CR7","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1023\/A:1022869222652","volume":"28","author":"E Giacobini","year":"2003","unstructured":"Giacobini E (2003) Cholinesterases: new roles in brain function and in Alzheimer\u2019s disease. Neurochem Res 28(3\u20134):515\u2013522","journal-title":"Neurochem Res"},{"issue":"2","key":"10292_CR8","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1080\/1061186X.2018.1474361","volume":"27","author":"K Lao","year":"2019","unstructured":"Lao K, Ji N, Zhang X, Qiao W, Tang Z, Gou X (2019) Drug development for Alzheimer\u2019s disease: review. J Drug Target 27(2):164\u2013173","journal-title":"J Drug Target"},{"issue":"1","key":"10292_CR9","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1021\/bi00349a019","volume":"25","author":"M Bazelyansky","year":"1986","unstructured":"Bazelyansky M, Robey E, Kirsch JF (1986) Fractional diffusion-limited component of reactions catalyzed by acetylcholinesterase. Biochemistry 25(1):125\u2013130","journal-title":"Biochemistry"},{"issue":"8","key":"10292_CR10","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1002\/ardp.201300045","volume":"346","author":"MD Alt\u0131ntop","year":"2013","unstructured":"Alt\u0131ntop MD, Gurkan-Alp AS, \u00d6zkay Y, Kaplanc\u0131kl\u0131 ZA (2013) Synthesis and biological evaluation of a series of dithiocarbamates as new cholinesterase inhibitors. Arch Pharm 346(8):571\u2013576","journal-title":"Arch Pharm"},{"issue":"12","key":"10292_CR11","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.3390\/molecules22122098","volume":"22","author":"TL Rosenberry","year":"2017","unstructured":"Rosenberry TL, Brazzolotto X, Macdonald IR, Wandhammer M, Trovaslet-Leroy M, Darvesh S et al (2017) Comparison of the binding of reversible inhibitors to human butyrylcholinesterase and acetylcholinesterase: a crystallographic, kinetic and calorimetric study. Molecules 22(12):2098","journal-title":"Molecules"},{"issue":"Pt 1","key":"10292_CR12","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1042\/bj3350095","volume":"335","author":"N Ariel","year":"1998","unstructured":"Ariel N, Ordentlich A, Barak D, Bino T, Velan B, Shafferman A (1998) The \u201caromatic patch\u201d of three proximal residues in the human acetylcholinesterase active centre allows for versatile interaction modes with inhibitors. Biochem J 335(Pt 1):95\u2013102","journal-title":"Biochem J"},{"issue":"19","key":"10292_CR13","doi-asserted-by":"publisher","first-page":"9031","DOI":"10.1073\/pnas.90.19.9031","volume":"90","author":"M Harel","year":"1993","unstructured":"Harel M, Schalk I, Ehret-Sabatier L, Bouet F, Goeldner M, Hirth C et al (1993) Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase. Proc Natl Acad Sci U S A 90(19):9031\u20139035","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10292_CR14","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1021\/bi9813577","volume":"38","author":"T Szegletes","year":"1999","unstructured":"Szegletes T, Mallender WD, Thomas PJ, Rosenberry TL (1999) Substrate binding to the peripheral site of acetylcholinesterase initiates enzymatic catalysis. Substrate inhibition arises as a secondary effect. Biochemistry 38(1):122\u2013133","journal-title":"Biochemistry"},{"issue":"3","key":"10292_CR15","doi-asserted-by":"publisher","first-page":"703","DOI":"10.3390\/ijms21030703","volume":"21","author":"VD Mouchlis","year":"2020","unstructured":"Mouchlis VD, Melagraki G, Zacharia LC, Afantitis A (2020) Computer-aided drug design of beta-secretase, gamma-secretase and anti-tau inhibitors for the discovery of novel Alzheimer\u2019s therapeutics. Int J Mol Sci 21(3):703","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10292_CR16","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1186\/s12859-019-3135-4","volume":"20","author":"S Kwon","year":"2019","unstructured":"Kwon S, Bae H, Jo J, Yoon S (2019) Comprehensive ensemble in QSAR prediction for drug discovery. BMC Bioinform 20(1):521","journal-title":"BMC Bioinform"},{"issue":"10","key":"10292_CR17","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.2174\/156802607780906771","volume":"7","author":"H Gonz\u00e1lez-D\u00edaz","year":"2007","unstructured":"Gonz\u00e1lez-D\u00edaz H, Vilar S, Santana L, Uriarte E (2007) Medicinal chemistry and bioinformatics\u2013current trends in drugs discovery with networks topological indices. Curr Top Med Chem 7(10):1015\u20131029","journal-title":"Curr Top Med Chem"},{"issue":"11","key":"10292_CR18","doi-asserted-by":"publisher","first-page":"3525","DOI":"10.1039\/D0CS00098A","volume":"49","author":"EN Muratov","year":"2020","unstructured":"Muratov EN, Bajorath J, Sheridan RP, Tetko IV, Filimonov D, Poroikov V et al (2020) QSAR without borders. Chem Soc Rev 49(11):3525\u20133564","journal-title":"Chem Soc Rev"},{"issue":"6","key":"10292_CR19","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.3390\/molecules25061292","volume":"25","author":"AA Toropov","year":"2020","unstructured":"Toropov AA, Toropova AP (2020) QSPR\/QSAR: state-of-art, weirdness, the future. Molecules 25(6):1292","journal-title":"Molecules"},{"issue":"6","key":"10292_CR20","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1007\/s11427-007-0094-1","volume":"50","author":"A Liu","year":"2007","unstructured":"Liu A, Guang H, Zhu L, Du G, Lee SM, Wang Y (2007) 3D-QSAR analysis of a new type of acetylcholinesterase inhibitors. Sci China C Life Sci 50(6):726\u2013730","journal-title":"Sci China C Life Sci"},{"issue":"3","key":"10292_CR21","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0009-2797(97)00047-1","volume":"105","author":"M Recanatini","year":"1997","unstructured":"Recanatini M, Cavalli A, Hansch C (1997) A comparative QSAR analysis of acetylcholinesterase inhibitors currently studied for the treatment of Alzheimer\u2019s disease. Chem Biol Interact 105(3):199\u2013228","journal-title":"Chem Biol Interact"},{"issue":"12","key":"10292_CR22","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1111\/j.1745-7254.2007.00664.x","volume":"28","author":"L-I Shen","year":"2007","unstructured":"Shen L-I, Liu G-X, Tang Y (2007) Molecular docking and 3D-QSAR studies of 2-substituted 1-indanone derivatives as acetylcholinesterase inhibitors. Acta Pharmacol Sin 28(12):2053\u20132063","journal-title":"Acta Pharmacol Sin"},{"issue":"2","key":"10292_CR23","doi-asserted-by":"publisher","first-page":"106","DOI":"10.2174\/157018007779422505","volume":"4","author":"MS Castilho","year":"2007","unstructured":"Castilho MS, Guido RVC, Andricopulo AD (2007) Classical and hologram QSAR studies on a series of tacrine derivatives as butyrylcholinesterase inhibitors. Lett Drug Des Discov 4(2):106\u2013113","journal-title":"Lett Drug Des Discov"},{"key":"10292_CR24","unstructured":"Nour El Houda H, Yacine B, Widad S (2020) QSAR modeling of thirty active compounds for the inhibition of the acetylcholinesterase enzyme. Curr Res Bioinform 8(1)"},{"issue":"4","key":"10292_CR25","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.3390\/ijms20041000","volume":"20","author":"M Son","year":"2019","unstructured":"Son M, Park C, Rampogu S, Zeb A, Lee KW (2019) Discovery of novel acetylcholinesterase inhibitors as potential candidates for the treatment of Alzheimer\u2019s disease. Int J Mol Sci 20(4):1000","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10292_CR26","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s00044-019-02330-8","volume":"28","author":"A Karmakar","year":"2019","unstructured":"Karmakar A, Ambure P, Mallick T, Das S, Roy K, Begum NA (2019) Exploration of synthetic antioxidant flavonoid analogs as acetylcholinesterase inhibitors: an approach towards finding their quantitative structure\u2013activity relationship. Med Chem Res 28(5):723\u2013741","journal-title":"Med Chem Res"},{"key":"10292_CR27","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.bioorg.2017.07.013","volume":"74","author":"J Wiemann","year":"2017","unstructured":"Wiemann J, Loesche A, Csuk R (2017) Novel dehydroabietylamine derivatives as potent inhibitors of acetylcholinesterase. Bioorg Chem 74:145\u2013157","journal-title":"Bioorg Chem"},{"key":"10292_CR28","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.2322","volume":"4","author":"S Simeon","year":"2016","unstructured":"Simeon S, Anuwongcharoen N, Shoombuatong W, Malik AA, Prachayasittikul V, Wikberg JES et al (2016) Probing the origins of human acetylcholinesterase inhibition via QSAR modeling and molecular docking. PeerJ 4:e2322","journal-title":"PeerJ"},{"issue":"11","key":"10292_CR29","doi-asserted-by":"publisher","first-page":"3342","DOI":"10.1080\/07391102.2019.1660218","volume":"38","author":"K Sahin","year":"2020","unstructured":"Sahin K, Zengin Kurt B, Sonmez F, Durdagi S (2020) Novel AChE and BChE inhibitors using combined virtual screening, text mining and in vitro binding assays. J Biomol Struct Dyn 38(11):3342\u20133358","journal-title":"J Biomol Struct Dyn"},{"key":"10292_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiolchem.2020.107355","volume":"88","author":"V Kumar","year":"2020","unstructured":"Kumar V, Saha A, Roy K (2020) In silico modeling for dual inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) enzymes in Alzheimer\u2019s disease. Comput Biol Chem 88:107355","journal-title":"Comput Biol Chem"},{"issue":"1","key":"10292_CR31","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1080\/14756366.2018.1543288","volume":"34","author":"H Cavdar","year":"2019","unstructured":"Cavdar H, Senturk M, Guney M, Durdagi S, Kayik G, Supuran CT et al (2019) Inhibition of acetylcholinesterase and butyrylcholinesterase with uracil derivatives: kinetic and computational studies. J Enzyme Inhib Med Chem 34(1):429\u2013437","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"1","key":"10292_CR32","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1080\/14756366.2017.1347163","volume":"32","author":"B Feng","year":"2017","unstructured":"Feng B, Li X, Xia J, Wu S (2017) Discovery of novel isoflavone derivatives as AChE\/BuChE dual-targeted inhibitors: synthesis, biological evaluation and molecular modelling. J Enzyme Inhib Med Chem 32(1):968\u2013977","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"6","key":"10292_CR33","doi-asserted-by":"publisher","first-page":"3429","DOI":"10.1039\/C6RA25887E","volume":"7","author":"Y Chen","year":"2017","unstructured":"Chen Y, Lin H, Yang H, Tan R, Bian Y, Fu T et al (2017) Discovery of new acetylcholinesterase and butyrylcholinesterase inhibitors through structure-based virtual screening. RSC Adv 7(6):3429\u20133438","journal-title":"RSC Adv"},{"issue":"4","key":"10292_CR34","doi-asserted-by":"publisher","first-page":"444","DOI":"10.4103\/0253-7613.161274","volume":"47","author":"S Kumar","year":"2015","unstructured":"Kumar S (2015) Dual inhibition of acetylcholinesterase and butyrylcholinesterase enzymes by allicin. Indian J Pharmacol 47(4):444\u2013446","journal-title":"Indian J Pharmacol"},{"key":"10292_CR35","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/291214","volume":"2014","author":"S Gupta","year":"2014","unstructured":"Gupta S, Mohan CG (2014) Dual binding site and selective acetylcholinesterase inhibitors derived from integrated pharmacophore models and sequential virtual screening. Biomed Res Int 2014:291214","journal-title":"Biomed Res Int"},{"issue":"12","key":"10292_CR36","doi-asserted-by":"publisher","first-page":"3588","DOI":"10.1021\/jm8001313","volume":"51","author":"P Camps","year":"2008","unstructured":"Camps P, Formosa X, Galdeano C, G\u00f3mez T, Mu\u00f1oz-Torrero D, Scarpellini M et al (2008) Novel donepezil-based inhibitors of acetyl- and butyrylcholinesterase and acetylcholinesterase-induced \u03b2-amyloid aggregation. J Med Chem 51(12):3588\u20133598","journal-title":"J Med Chem"},{"issue":"D1","key":"10292_CR37","doi-asserted-by":"publisher","first-page":"D930","DOI":"10.1093\/nar\/gky1075","volume":"47","author":"D Mendez","year":"2019","unstructured":"Mendez D, Gaulton A, Bento AP, Chambers J, De Veij M, Felix E et al (2019) ChEMBL: towards direct deposition of bioassay data. Nucl Acids Res 47(D1):D930\u2013D940","journal-title":"Nucl Acids Res"},{"issue":"1","key":"10292_CR38","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13321-017-0232-0","volume":"9","author":"EB Lenselink","year":"2017","unstructured":"Lenselink EB, Ten Dijke N, Bongers B, Papadatos G, van Vlijmen HWT, Kowalczyk W et al (2017) Beyond the hype: deep neural networks outperform established methods using a ChEMBL bioactivity benchmark set. J Cheminform 9(1):45","journal-title":"J Cheminform"},{"key":"10292_CR39","doi-asserted-by":"crossref","unstructured":"Nidhi, Glick M, Davies JW, Jenkins JL (2006) Prediction of biological targets for compounds using multiple-category Bayesian models trained on chemogenomics databases. J Chem Inf Model 46(3):1124\u20131133","DOI":"10.1021\/ci060003g"},{"issue":"8","key":"10292_CR40","doi-asserted-by":"publisher","first-page":"719","DOI":"10.2174\/138620707782507313","volume":"10","author":"A Bender","year":"2007","unstructured":"Bender A, Young DW, Jenkins JL, Serrano M, Mikhailov D, Clemons PA et al (2007) Chemogenomic data analysis: prediction of small-molecule targets and the advent of biological fingerprint. Comb Chem High Throughput Screen 10(8):719\u2013731","journal-title":"Comb Chem High Throughput Screen"},{"issue":"20","key":"10292_CR41","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1002\/jcc.26223","volume":"41","author":"AA Malik","year":"2020","unstructured":"Malik AA, Phanus-Umporn C, Schaduangrat N, Shoombuatong W, Isarankura-Na-Ayudhya C, Nantasenamat C (2020) HCVpred: a web server for predicting the bioactivity of hepatitis C virus NS5B inhibitors. J Comput Chem 41(20):1820\u20131834","journal-title":"J Comput Chem"},{"issue":"21","key":"10292_CR42","doi-asserted-by":"publisher","first-page":"11344","DOI":"10.1039\/C7RA10979B","volume":"8","author":"N Suvannang","year":"2018","unstructured":"Suvannang N, Preeyanon L, Malik AA, Schaduangrat N, Shoombuatong W, Worachartcheewan A et al (2018) Probing the origin of estrogen receptor alpha inhibition via large-scale QSAR study. RSC Adv 8(21):11344\u201311356","journal-title":"RSC Adv"},{"issue":"11","key":"10292_CR43","doi-asserted-by":"publisher","first-page":"5920","DOI":"10.1039\/C7RA12079F","volume":"8","author":"C Phanus-umporn","year":"2018","unstructured":"Phanus-umporn C, Shoombuatong W, Prachayasittikul V, Anuwongcharoen N, Nantasenamat C (2018) Privileged substructures for anti-sickling activity via cheminformatic analysis. RSC Adv 8(11):5920\u20135935","journal-title":"RSC Adv"},{"key":"10292_CR44","volume-title":"Molecular descriptors for chemoinformatics","author":"R Todeschini","year":"2010","unstructured":"Todeschini R, Consonni V (2010) Molecular descriptors for chemoinformatics, 2nd edn. Wiley-VCH Verlag GmbH, Weinheim","edition":"2"},{"issue":"7","key":"10292_CR45","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1002\/jcc.21707","volume":"32","author":"CW Yap","year":"2011","unstructured":"Yap CW (2011) PaDEL-descriptor: an open source software to calculate molecular descriptors and fingerprints. J Comput Chem 32(7):1466\u20131474","journal-title":"J Comput Chem"},{"issue":"1","key":"10292_CR46","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13321-018-0258-y","volume":"10","author":"H Moriwaki","year":"2018","unstructured":"Moriwaki H, Tian YS, Kawashita N, Takagi T (2018) Mordred: a molecular descriptor calculator. J Cheminform 10(1):4","journal-title":"J Cheminform"},{"issue":"1","key":"10292_CR47","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1080\/00401706.1969.10490666","volume":"11","author":"RW Kennard","year":"1969","unstructured":"Kennard RW, Stone LA (1969) Computer aided design of experiments. Technometrics 11(1):137\u2013148","journal-title":"Technometrics"},{"key":"10292_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-9752-7_1","volume":"2053","author":"M W\u00f3jcikowski","year":"2019","unstructured":"W\u00f3jcikowski M, Siedlecki P, Ballester PJ (2019) Building machine-learning scoring functions for structure-based prediction of intermolecular binding affinity. Methods Mol Biol 2053:1\u201312","journal-title":"Methods Mol Biol"},{"issue":"1","key":"10292_CR49","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman L (2001) Random forests. Mach Learn 45(1):5\u201332","journal-title":"Mach Learn"},{"issue":"3","key":"10292_CR50","first-page":"18","volume":"2","author":"A Liaw","year":"2002","unstructured":"Liaw A, Wiener M (2002) Classification and regression by randomForest. R News 2(3):18\u201322","journal-title":"R News"},{"issue":"4","key":"10292_CR51","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1021\/ci034288y","volume":"44","author":"J Song","year":"2004","unstructured":"Song J, Tang H (2004) Accurate classification of homodimeric vs other homooligomeric proteins using a new measure of information discrepancy. J Chem Inf Comput Sci 44(4):1324\u20131327","journal-title":"J Chem Inf Comput Sci"},{"issue":"1\u20133","key":"10292_CR52","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","volume":"46","author":"CA Lipinski","year":"2001","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46(1\u20133):3\u201326","journal-title":"Adv Drug Deliv Rev"},{"issue":"5","key":"10292_CR53","doi-asserted-by":"publisher","first-page":"4791","DOI":"10.3390\/molecules17054791","volume":"17","author":"F Sahigara","year":"2012","unstructured":"Sahigara F, Mansouri K, Ballabio D, Mauri A, Consonni V, Todeschini R (2012) Comparison of different approaches to define the applicability domain of QSAR models. Molecules 17(5):4791\u20134810","journal-title":"Molecules"},{"issue":"1","key":"10292_CR54","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/cbdd.13064","volume":"91","author":"C Yoo","year":"2018","unstructured":"Yoo C, Shahlaei M (2018) The applications of PCA in QSAR studies: a case study on CCR5 antagonists. Chem Biol Drug Des 91(1):137\u2013152","journal-title":"Chem Biol Drug Des"},{"key":"10292_CR55","unstructured":"Organisation for Economic Co-operation and Development (2007) Guidance document on the validation of (quantitative) structure activity relationship [(Q)SAR] models"},{"issue":"1","key":"10292_CR56","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13321-020-0408-x","volume":"12","author":"N Schaduangrat","year":"2020","unstructured":"Schaduangrat N, Lampa S, Simeon S, Gleeson MP, Spjuth O, Nantasenamat C (2020) Towards reproducible computational drug discovery. J Cheminform 12(1):9","journal-title":"J Cheminform"},{"issue":"1","key":"10292_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0169-7439(96)00023-8","volume":"34","author":"L Eriksson","year":"1996","unstructured":"Eriksson L, Johansson E (1996) Multivariate design and modeling in QSAR. Chemom Intell Lab Syst 34(1):1\u201319","journal-title":"Chemom Intell Lab Syst"},{"issue":"1","key":"10292_CR58","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1093\/bib\/bbq011","volume":"12","author":"ML Calle","year":"2011","unstructured":"Calle ML, Urrea V (2011) Letter to the editor: stability of random forest importance measures. Brief Bioinform 12(1):86\u201389","journal-title":"Brief Bioinform"},{"issue":"27","key":"10292_CR59","doi-asserted-by":"publisher","first-page":"21249","DOI":"10.1039\/C5RA00906E","volume":"5","author":"I Khan","year":"2015","unstructured":"Khan I, Bakht SM, Ibrar A, Abbas S, Hameed S, White JM et al (2015) Exploration of a library of triazolothiadiazole and triazolothiadiazine compounds as a highly potent and selective family of cholinesterase and monoamine oxidase inhibitors: design, synthesis, X-ray diffraction analysis and molecular docking studies. RSC Adv 5(27):21249\u201321267","journal-title":"RSC Adv"},{"issue":"1","key":"10292_CR60","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1186\/s40064-016-2996-5","volume":"5","author":"A Rahman","year":"2016","unstructured":"Rahman A, Ali MT, Shawan MM, Sarwar MG, Khan MA, Halim MA (2016) Halogen-directed drug design for Alzheimer\u2019s disease: a combined density functional and molecular docking study. SpringerPlus 5(1):1346","journal-title":"SpringerPlus"},{"issue":"6","key":"10292_CR61","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1016\/j.bmc.2007.12.048","volume":"16","author":"SD Bembenek","year":"2008","unstructured":"Bembenek SD, Keith JM, Letavic MA, Apodaca R, Barbier AJ, Dvorak L et al (2008) Lead identification of acetylcholinesterase inhibitors-histamine H3 receptor antagonists from molecular modeling. Bioorg Med Chem 16(6):2968\u20132973","journal-title":"Bioorg Med Chem"},{"issue":"9","key":"10292_CR62","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.1016\/j.bmcl.2012.03.046","volume":"22","author":"Y Chen","year":"2012","unstructured":"Chen Y, Fang L, Peng S, Liao H, Lehmann J, Zhang Y (2012) Discovery of a novel acetylcholinesterase inhibitor by structure-based virtual screening techniques. Bioorg Med Chem Lett 22(9):3181\u20133187","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"10292_CR63","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1021\/cc9800071","volume":"1","author":"AK Ghose","year":"1999","unstructured":"Ghose AK, Viswanadhan VN, Wendoloski JJ (1999) A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. J Comb Chem 1(1):55\u201368","journal-title":"J Comb Chem"},{"issue":"9","key":"10292_CR64","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.3390\/molecules23092382","volume":"23","author":"P Acosta-Guzm\u00e1n","year":"2018","unstructured":"Acosta-Guzm\u00e1n P, Mateus-G\u00f3mez A, Gamba-S\u00e1nchez D (2018) Direct transamidation reactions: mechanism and recent advances. Molecules 23(9):2382","journal-title":"Molecules"},{"issue":"6","key":"10292_CR65","first-page":"765","volume":"9","author":"JW Bode","year":"2006","unstructured":"Bode JW (2006) Emerging methods in amide- and peptide-bond formation. Curr Opin Drug Discov Devel 9(6):765\u2013775","journal-title":"Curr Opin Drug Discov Devel"},{"key":"10292_CR66","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13065-015-0107-2","volume":"9","author":"A Sadiq","year":"2015","unstructured":"Sadiq A, Mahmood F, Ullah F, Ayaz M, Ahmad S, Haq FU et al (2015) Synthesis, anticholinesterase and antioxidant potentials of ketoesters derivatives of succinimides: a possible role in the management of Alzheimer\u2019s. Chem Cent J 9:31","journal-title":"Chem Cent J"},{"key":"10292_CR67","first-page":"219","volume":"43","author":"M Weinstock","year":"1994","unstructured":"Weinstock M, Razin M, Chorev M, Enz A (1994) Pharmacological evaluation of phenyl-carbamates as CNS-selective acetylcholinesterase inhibitors. J Neural Transm Suppl 43:219\u2013225","journal-title":"J Neural Transm Suppl"},{"issue":"10","key":"10292_CR68","doi-asserted-by":"publisher","first-page":"691","DOI":"10.2165\/11593300-000000000-00000","volume":"31","author":"L Maggi","year":"2011","unstructured":"Maggi L, Mantegazza R (2011) Treatment of myasthenia gravis: focus on pyridostigmine. Clin Drug Investig 31(10):691\u2013701","journal-title":"Clin Drug Investig"},{"issue":"4","key":"10292_CR69","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.3233\/JAD-2010-101311","volume":"22","author":"B Winblad","year":"2010","unstructured":"Winblad B, Giacobini E, Frolich L, Friedhoff LT, Bruinsma G, Becker RE et al (2010) Phenserine efficacy in Alzheimer\u2019s disease. J Alzheimers Dis 22(4):1201\u20131208","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"10292_CR70","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3390\/molecules21020191","volume":"21","author":"M Kratky","year":"2016","unstructured":"Kratky M, Stepankova S, Vorcakova K, Svarcova M, Vinsova J (2016) Novel cholinesterase inhibitors based on O-aromatic N, N-disubstituted carbamates and thiocarbamates. Molecules 21(2):191","journal-title":"Molecules"},{"key":"10292_CR71","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0009-2797(99)00014-9","volume":"119\u2013120","author":"A Saxena","year":"1999","unstructured":"Saxena A, Redman AM, Jiang X, Lockridge O, Doctor BP (1999) Differences in active-site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase. Chem Biol Interact 119\u2013120:61\u201369","journal-title":"Chem Biol Interact"},{"issue":"14","key":"10292_CR72","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1021\/jm8002075","volume":"51","author":"S Darvesh","year":"2008","unstructured":"Darvesh S, Darvesh KV, McDonald RS, Mataija D, Walsh R, Mothana S et al (2008) Carbamates with differential mechanism of inhibition toward acetylcholinesterase and butyrylcholinesterase. J Med Chem 51(14):4200\u20134212","journal-title":"J Med Chem"},{"issue":"1","key":"10292_CR73","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s13065-018-0497-z","volume":"12","author":"SK Yusufzai","year":"2018","unstructured":"Yusufzai SK, Khan MS, Sulaiman O, Osman H, Lamjin DN (2018) Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A\/B and \u03b2-amyloid inhibitors for Alzheimer\u2019s disease. Chem Cent J 12(1):128","journal-title":"Chem Cent J"},{"issue":"45","key":"10292_CR74","doi-asserted-by":"publisher","first-page":"12074","DOI":"10.1021\/bi00096a018","volume":"32","author":"Z Radic","year":"1993","unstructured":"Radic Z, Pickering NA, Vellom DC, Camp S, Taylor P (1993) Three distinct domains in the cholinesterase molecule confer selectivity for acetyl- and butyrylcholinesterase inhibitors. Biochemistry 32(45):12074\u201312084","journal-title":"Biochemistry"},{"issue":"42","key":"10292_CR75","doi-asserted-by":"publisher","first-page":"41141","DOI":"10.1074\/jbc.M210241200","volume":"278","author":"Y Nicolet","year":"2003","unstructured":"Nicolet Y, Lockridge O, Masson P, Fontecilla-Camps JC, Nachon F (2003) Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products. J Biol Chem 278(42):41141\u201341147","journal-title":"J Biol Chem"},{"issue":"26","key":"10292_CR76","doi-asserted-by":"publisher","first-page":"7753","DOI":"10.1021\/bi000210o","volume":"39","author":"WD Mallender","year":"2000","unstructured":"Mallender WD, Szegletes T, Rosenberry TL (2000) Acetylthiocholine binds to asp74 at the peripheral site of human acetylcholinesterase as the first step in the catalytic pathway. Biochemistry 39(26):7753\u20137763","journal-title":"Biochemistry"},{"issue":"1","key":"10292_CR77","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.cbi.2012.08.005","volume":"203","author":"M Wandhammer","year":"2013","unstructured":"Wandhammer M, de Koning M, van Grol M, Loiodice M, Saurel L, Noort D et al (2013) A step toward the reactivation of aged cholinesterases\u2013crystal structure of ligands binding to aged human butyrylcholinesterase. Chem Biol Interact 203(1):19\u201323","journal-title":"Chem Biol Interact"},{"issue":"16","key":"10292_CR78","doi-asserted-by":"publisher","first-page":"7683","DOI":"10.1021\/acs.jmedchem.6b00356","volume":"59","author":"SN Dighe","year":"2016","unstructured":"Dighe SN, Deora GS, De la Mora E, Nachon F, Chan S, Parat MO et al (2016) Discovery and structure-activity relationships of a highly selective butyrylcholinesterase inhibitor by structure-based virtual screening. J Med Chem 59(16):7683\u20137689","journal-title":"J Med Chem"},{"issue":"5","key":"10292_CR79","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1046\/j.1532-5415.2002.50208.x","volume":"50","author":"CM Roe","year":"2002","unstructured":"Roe CM, Anderson MJ, Spivack B (2002) Use of anticholinergic medications by older adults with dementia. J Am Geriatr Soc 50(5):836\u2013842","journal-title":"J Am Geriatr Soc"},{"key":"10292_CR80","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.ejmech.2016.10.042","volume":"124","author":"BN Saglik","year":"2016","unstructured":"Saglik BN, Ilgin S, Ozkay Y (2016) Synthesis of new donepezil analogues and investigation of their effects on cholinesterase enzymes. Eur J Med Chem 124:1026\u20131040","journal-title":"Eur J Med Chem"},{"issue":"6","key":"10292_CR81","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1016\/j.pharep.2017.06.009","volume":"69","author":"\u00dcD \u00d6zkay","year":"2017","unstructured":"\u00d6zkay \u00dcD, Can \u00d6D, Sa\u011fl\u0131k BN, Turan N (2017) A benzothiazole\/piperazine derivative with acetylcholinesterase inhibitory activity: Improvement in streptozotocin-induced cognitive deficits in rats. Pharmacol Rep 69(6):1349\u20131356","journal-title":"Pharmacol Rep"},{"key":"10292_CR82","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.ejmech.2016.09.057","volume":"125","author":"CB Mishra","year":"2017","unstructured":"Mishra CB, Kumari S, Manral A, Prakash A, Saini V, Lynn AM et al (2017) Design, synthesis, in-silico and biological evaluation of novel donepezil derivatives as multi-target-directed ligands for the treatment of Alzheimer\u2019s disease. Eur J Med Chem 125:736\u2013750","journal-title":"Eur J Med Chem"},{"issue":"12","key":"10292_CR83","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1002\/cmdc.201500418","volume":"11","author":"D Dolles","year":"2016","unstructured":"Dolles D, Nimczick M, Scheiner M, Ramler J, Stadtmuller P, Sawatzky E et al (2016) Aminobenzimidazoles and structural isomers as templates for dual-acting butyrylcholinesterase inhibitors and hCB2 R ligands to combat neurodegenerative disorders. ChemMedChem 11(12):1270\u20131283","journal-title":"ChemMedChem"},{"issue":"3","key":"10292_CR84","doi-asserted-by":"publisher","first-page":"5608","DOI":"10.3390\/ijms14035608","volume":"14","author":"M Bajda","year":"2013","unstructured":"Bajda M, Wieckowska A, Hebda M, Guzior N, Sotriffer CA, Malawska B (2013) Structure-based search for new inhibitors of cholinesterases. Int J Mol Sci 14(3):5608\u20135632","journal-title":"Int J Mol Sci"},{"key":"10292_CR85","doi-asserted-by":"publisher","first-page":"D198","DOI":"10.1093\/nar\/gkl999","volume":"35","author":"T Liu","year":"2007","unstructured":"Liu T, Lin Y, Wen X, Jorissen RN, Gilson MK (2007) BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities. Nucl Acids Res 35:D198-201","journal-title":"Nucl Acids Res"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-021-10292-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-021-10292-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-021-10292-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T08:16:53Z","timestamp":1675757813000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-021-10292-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,5]]},"references-count":85,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["10292"],"URL":"https:\/\/doi.org\/10.1007\/s11030-021-10292-6","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,5]]},"assertion":[{"value":"12 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}